VPS35 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.246800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.220000E-01
Normal-vs-Stage2
8.810800E-01
Normal-vs-Stage3
2.768600E-01
Normal-vs-Stage4
1.441400E-01
Stage1-vs-Stage2
3.008200E-01
Stage1-vs-Stage3
6.501600E-01
Stage1-vs-Stage4
2.730200E-02
Stage2-vs-Stage3
1.935950E-01
Stage2-vs-Stage4
4.024500E-03
Stage3-vs-Stage4
3.923800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.574000E-01
Normal-vs-AfricanAmerican
6.464600E-01
Normal-vs-Asian
8.431200E-01
Caucasian-vs-AfricanAmerican
5.317600E-01
Caucasian-vs-Asian
5.892800E-01
AfricanAmerican-vs-Asian
4.463200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.275000E-01
Normal-vs-Female
9.270400E-01
Male-vs-Female
9.823200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.935000E-01
Normal-vs-Age(41-60Yrs)
5.970400E-01
Normal-vs-Age(61-80Yrs)
9.015000E-01
Normal-vs-Age(81-100Yrs)
9.941400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.627400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.605800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.420200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.937670E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.464400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.027600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.871400E-01
Normal-vs-Daily Drinker
6.109200E-01
Normal-vs-Weekly Drinker
5.748400E-01
Normal-vs-Occasional Drinker
4.533600E-01
Normal-vs-Social Drinker
9.058800E-01
Non Drinker-vs-Daily Drinker
4.145800E-01
Non Drinker-vs-Weekly Drinker
4.802600E-01
Non Drinker-vs-Occasional Drinker
5.717800E-02
Non Drinker-vs-Social Drinker
6.299400E-01
Daily Drinker-vs-Weekly Drinker
9.673400E-01
Daily Drinker-vs-Occasional Drinker
1.943720E-02
Daily Drinker-vs-Social Drinker
2.509800E-01
Weekly Drinker-vs-Occasional Drinker
3.346000E-02
Weekly Drinker-vs-Social Drinker
2.681000E-01
Occasional Drinker-vs-Social Drinker
2.052200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.795990E-01
Normal-vs-Grade 2
2.950400E-02
Normal-vs-Grade 3
2.138500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.037950E-02
Grade 1-vs-Grade 3
2.143600E-03
Grade 1-vs-Grade 4
1.795990E-01
Grade 2-vs-Grade 3
2.288000E-01
Grade 2-vs-Grade 4
2.950400E-02
Grade 3-vs-Grade 4
2.138500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.396600E-01
Normal-vs-NonDiabetic
9.616600E-01
Diabetic-vs-NonDiabetic
4.323800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.746600E-01
Normal-vs-NoPancreatitis
9.670800E-01
Pancreatitis-vs-NoPancreatitis
7.549000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.729000E-01
Normal-vs-N1
8.487800E-01
N0-vs-N1
5.856400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.480800E-01
Normal-vs-TP53-NonMutant
7.735000E-01
TP53-Mutant-vs-TP53-NonMutant
3.65119999999886E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
